T-cell receptor specific for Purified Protein Derivative-derived peptide–Major Histocompatibility Complex class II complex (PPD-specific TCR)

T-cell receptors (TCRs) specific for Purified Protein Derivative (PPD)-derived peptide–MHC class II complexes are essential mediators of the adaptive immune response against Mycobacterium tuberculosis. These receptors are primarily expressed on the surface of CD4+ T lymphocytes and function by recognizing a complex mixture of mycobacterial antigens, such as the Ag85 complex and other secreted proteins, when they are processed and presented by Major Histocompatibility Complex (MHC) class II molecules (NIH, 2021). Upon successful binding to the peptide-MHC complex, the TCR initiates intracellular signaling pathways that lead to the activation of the T cell, resulting in the secretion of pro-inflammatory cytokines like interferon-gamma (IFN-γ) and tumor necrosis factor-alpha (TNF-α) (PubMed, PMID: 15661903). This specific interaction is the biological foundation for the Tuberculin Skin Test (TST) and Interferon-Gamma Release Assays (IGRAs), which are the gold standards for diagnosing tuberculosis infection (CDC, 2023). In therapeutic development, these TCRs are targets for vaccine strategies, such as the BCG vaccine, which aims to prime these receptors for a rapid response upon subsequent exposure to the pathogen. Furthermore, research into TCR-engineered T-cell therapies explores the potential of enhancing these specific receptors to provide better protection or treatment for multi-drug resistant tuberculosis (Nature Communications, 2020). However, the high degree of polymorphism in human HLA genes and the antigenic complexity of PPD present significant challenges for achieving uniform therapeutic efficacy across different populations.

Other names

PPD-reactive T-cell receptorMycobacterium tuberculosis-specific T-cell receptorTCR-PPD-MHCII complexTuberculin-reactive T-cell receptor

The receptor binds to specific mycobacterial peptides presented by MHC class II molecules on antigen-presenting cells, triggering the CD3 signaling complex to initiate T-cell proliferation and the release of Th1 cytokines such as interferon-gamma.